focus -WSS

focus

author：knowledge 2025-10-02 00:28:53 - browse：931

The term “excited delirium” has been used for years by law enforcement and other first responders, including health care workers, to describe people who exhibit behavior that is considered “out of control.” This diagnosis has been applied again and again, even posthumously, as a justification for extreme, and sometimes deadly, interventions by law enforcement. It came up most recently in the trials of two police officers accused of causing the death of Elijah McClain, a Colorado man; both officers were acquitted this week.

But excited delirium is not an evidence-based medical diagnosis. The American College of Emergency Physicians recently withdrew a 2009 white paper endorsing the concept, and California has banned it as a cause of death. Other states may follow suit.

On this week’s episode, we are joined by Utsha G. Khatri, an assistant professor of emergency medicine and population health and policy at the Icahn School of Medicine at Mount Sinai, and emergency physician Brooks Walsh, who was involved with the campaign to get ACEP to withdraw the 2009 white paper. Khatri and Walsh speak about why the “excited delirium” label is both unnecessary and dangerous.

“We recognize that some patients are confused. They’re not thinking clearly they might have risk for becoming violent either toward themselves or towards other staff,” Khatri said. “It is our job not just to keep them and everyone else safe, but also to most importantly find out what is causing them to act in this way.”

You can read Khatri’s First Opinion essay on the end of “excited delirium” here.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： FDA investigates CAR

Wikipedia

WSS

Flagship Pioneering launches a new biotech in two countries

Longer MASH drug regimen improved liver, Akero study finds

What to do when lifesaving products contribute to climate change

UnitedHealth’s Optum accused of antitrust violations in California

Fetal surgery at risk from Dobbs and new abortion restrictions

The EPA's new lead rule: How one expert crunched the numbers

leisure time

focus

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Pediatric cancer treatments threatened by a new FDA policy

DIEP, the 'gold standard' of breast reconstruction, is under threat

J&J to emphasize cancer drugs, stop much of its vaccine research

Wildfire smoke exposes gaps in outdoor worker protections

Families look for replacement for GSK asthma drug Flovent

How to save PrEP access — and even expand it

Cigna, Humana reportedly in talks to merge

Peter Hotez and the public health issue of online harassment

Harvard's David Sinclair gets blowback over aging

knowledge

The untold story of TV’s first prescription drug ad

What don’t we know about an Alzheimer’s drug side effect?

As biotech industry slumps, bioscience job market is upside down

He's 19 months old and has one of the world’s rarest diseases

Ancient Greek ideas underpin modern concepts of pregnancy

What don’t we know about an Alzheimer’s drug side effect?

Wikipedia

focus

knowledge

knowledge